Product Ref: BABAY46 Category: B
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
| Category | POM-V |
| Temperature | Ambient |
| MA/VM/EU No: | 00879/4119 |
| Species |
|
| VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_117659.PDF |
| NOAH Link | |
| Dosage | Dosage and administration To ensure a correct dosage, body weight (bw) should be determined as accurately as possible to avoid underdosing. Repeated injections should be made at different injection sites. Calves 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily for 3-5 days. For acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis administer 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily for 5 days. The product can be administered by slow intravenous or subcutaneous administration. Not more than 10 ml should be administered at one subcutaneous injection site. Sheep and goats 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by subcutaneous injection for 3 days. Not more than 6 ml should be administered at one subcutaneous injection site. Pigs 2.5 mg of enrofloxacin/kg bw, corresponding to 0.5 ml/10 kg bw, once daily by intramuscular injection for 3 days. For alimentary tract infection or septicaemia caused by Escherichia coli administer 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by intramuscular injection for 3 days. In pigs, the injection should be made in the neck at the ear base. Not more than 3 ml should be administered at one intramuscular injection site. Dogs and cats 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by subcutaneous injection for up to 5 days. Treatment may be initiated with injectable product and maintained with enrofloxacin tablets. Duration of treatment should be based on the duration of treatment approved for the appropriate indication in the product information of the tablet product. Use during pregnancy and lactation Laboratory studies in rats and rabbits have not produced any evidence of teratogenic effects but have shown evidence of foetotoxic effects at maternotoxic doses. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian. |
| Withdrawals | ng the elimination phase. Thus, in dogs, the co-administration of enrofloxacin and flunixin increased the AUC and the elimination half-life of flunixin and increased the elimination half-life and reduced the Cmax of enrofloxacin. In countries where feeding of fallen stock to scavenger bird populations is permitted as a conservation measure (see Commission Decision 2003/322/EC), the possible risk to hatching success should be considered before feeding carcasses of livestock recently treated with this product. User safety People with known hypersensitivity to fluoroquinolones should avoid any contact with the product. Avoid skin and eye contact. Wash any splashes from skin or eyes immediately with water. Wash hands after use. Do not eat, drink or smoke whilst handling the product. Care should be taken to avoid accidental self-injection. If accidental self-injection occurs seek medical advice immediately. Withdrawal periods •Calves Following intravenous injection: Meat and offal: 5 days. Following subcutaneous injection: Meat and offal: 12 days. Not authorised for use in cattle producing milk for human consumption. •Sheep Meat and offal: 4 days. Milk: 72 hours. •Goats Meat and offal: 6 days. Milk: 96 hours. •Pigs Meat and offal: 13 days. Environmental safety Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. |
Animally Vet Supplies is the trading name of Veterinary Meds Online Ltd.
Company No. 12665548 | VMR No. 7386568 | Copyright 2022© All rights Reserved
